← Back to Search

Aerobic Exercise for Cancer Survivors

N/A
Waitlist Available
Led By Ryan Marker
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary cancer diagnosis of breast, prostate, or colorectal cancer
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study the effects of excess body fat on fitness, hormone levels, and metabolic responses in cancer survivors. The study will include overweight, obese, and normal weight survivors of breast, prostate

Who is the study for?
This trial is for breast, prostate, or colorectal cancer survivors who are overweight or obese. They should have finished their cancer treatments between 6 months and 5 years ago and must be able to do supervised exercise with a doctor's clearance.
What is being tested?
The study tests how body fat affects fitness levels and the body's response to a standardized 15-week aerobic exercise program in terms of cardiorespiratory fitness (CRF) and insulin-like growth factor-1 (IGF-1).
What are the potential side effects?
While not drug-related, potential side effects from the aerobic exercise may include muscle soreness, fatigue, joint pain, or injury due to increased physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My cancer is either breast, prostate, or colorectal.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Intervention Adherence
Recruitment
Study Adherence
Secondary study objectives
Estimated VO2max
Serum IGF-1
Total visceral adiposity

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Aerobic exerciseExperimental Treatment1 Intervention
15-week standardized aerobic exercise intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Aerobic Exercise
2013
Completed Early Phase 1
~1350

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,810 Previous Clinical Trials
2,919,968 Total Patients Enrolled
Ryan MarkerPrincipal InvestigatorUniversity of Colorado, Denver
~4 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top